Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes

Completed

• Conditions: Hypertension; Type 2 Diabetes

• Registration Number: NCT00803660
• Lead Sponsor: AstraZeneca

Brief Summary

Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP\<130/80 mmHg. To observe the proportion of diabetic patients on antihypertensive treatment reaching the BP\<130/80 mmHg by treatment groups. To observe the proportion of patients achieving a therapeutic glycemic response defined as HbA1c=\<7%. To observe the proportion of patients achieving fasting plasma glucose\<110 mg%. To identify factors for not achieving BP\<130/80 mmHg. To describe percentage of patients with positive proteinuria (including microalbuminuria) by treatment groups .

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11
• Study First Submitted: 2008-12-03
• Study First Submitted QC: 2008-12-04
• Study First Posted: 2008-12-05
• Study Completion: 2009-05
• Status Verified: 2009-07
• Last Update Submitted: 2009-07-08
• Last Update Posted: 2009-07-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1060

Inclusion Criteria

• Provision of written informed consent
• Patient was diagnosed with type 2 diabetes
• Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey

Exclusion Criteria

• Patients are critically ill, had mental health problems or difficulty in communication
• Patients who are unwilling or unable to provide informed consent
• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number of patients achieving the BP<130/80 mmHg
The percentage of patients achieving the BP<130/80 mmHg

Secondary Outcome Measures

Name	Time	Method
The number and percentage of patients achieving the BP<130/80 mmHg by treatment groups
The number and percentage of patients achieving HbA1c=<7%
The number and percentage of patients achieving the FPG<110 mg%
The association between unachievement of BP<130/80 mmHg and other factors (age, gender, CV risk factors, CV and diabetes history, duration of type of treatment...)
The number and percentage of patients with positive proteinuria by treatment groups

Trial Locations

Locations (1)

Research Site; 🇻🇳 Tien Giang, Vietnam